The Middle East and Africa neurological biomarker market is expected to reach US$ 529.04 million by 2027 from US$ 232.80 million in 2019; it is estimated to grow at a CAGR of 11.0% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as rising prevalence of neurological diseases and growing focus on neurological biomarker research. On the other hand, concerns associated with the use of biomarkers such as the absence of pre-analytical tests are among the major factors that hinder the market growth.
Neurological biomarkers are molecules present in the cerebral spinal fluid (CSF) or blood that support the diagnosis of brain disorders and monitor disease progression. These biomarkers' primary sources are genetic mutations, metabolite levels, brain imaging, and changes in protein expression or post-translational modifications. This helps in the early detection of disease and less invasive diagnostics. It also allows faster drug development and is expected to be the effective treatment for Neurological disorders. Currently, research activities focused on biomarkers in neurodegenerative diseases are significantly increasing due to the surging incidence of Alzheimer’s and Parkinson’s diseases across Middle East and Africa. The World Alzheimer's Report 2017 estimated that 4.4 million people aged 60 years and above were living in South Africa, from which ~ 187,000 had Alzheimer’s dementia. Also, the introduction of digital biomarkers and the growing focus on neurological biomarker research are anticipated to propel the growth of the Middle East and Africa neurological biomarker market in the coming years.
The COVID-19 outbreak pandemic has adversely affected the countries in the Middle East and Africa. Patients suffering from severe health conditions such as neurological diseases have been witnessing delays in chronic disease treatment. However, many companies and research institutes are taking initiatives to accelerate research in the diagnosis, treatment, and prevention of the neurological complications that may be caused by COVID-19. Thus, the Middle East and Africa neurological biomarker market is facing challenges due to the COVID-19 outbreak.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Middle East and Africa Neurological Biomarkers MarketSegmentation
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By Product
- Proteomics Biomaker
- Genomics Biomarker
- Metabolomics Biomarker
- Imaging Biomarker
- Others
By Application
- Alzheimer's Disease
- Parkinson's Disease
- Schizophrenia
- Huntington's Disease
- Spinal Muscular Atrophy
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Clinical Diagnostics
- Research Organizations
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Abbott
- Bio-Rad Laboratories Inc.
- QIAGEN
- Immunarray Pvt. Ltd.
- Quest Diagnostics Incorporated
- Perkin Elmer, Inc
- MERCK KGaA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Neurological Biomarker Market – By Product
1.3.2 Middle East and Africa Neurological Biomarker Market – By Application
1.3.3 Middle East and Africa Neurological Biomarker Market – By End User
1.3.4 Middle East and Africa Neurological Biomarker Market – By Country
2. Neurological Biomarker Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Neurological Biomarker Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa – PEST Analysis
4.3 Expert Opinion
5. Neurological Biomarker Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Neurological Diseases
5.1.2 Growing Focus on Neurological Biomarker Research
5.2 Key Market Restraints
5.2.1 Concerns Associated with Biomarkers
5.3 Key Market Opportunities
5.3.1 Increasing Awareness of Neurological Diseases Coupled with Developing Healthcare Infrastructure
5.4 Future Trends
5.4.1 The Rising Trend of Precision/Personalized Healthcare
5.5 Impact analysis
6. Neurological Biomarker Market – Middle East and Africa Analysis
6.1 Middle East and Africa Neurological Biomarker Market Revenue Forecast and Analysis
7. Neurological Biomarker Market Analysis– by Product
7.1 Overview
7.2 Neurological Biomarker Market Share, By Product, 2019 & 2027 (%)
7.3 Proteomics Biomarker
7.3.1 Overview
7.3.2 Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Genomics Biomarker
7.4.1 Overview
7.4.2 Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Metabolomics Biomarker
7.5.1 Overview
7.5.2 Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Imaging Biomarker
7.6.1 Overview
7.6.2 Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Neurological Biomarker Market Analysis– by Application
8.1 Overview
8.2 Neurological Biomarker Market Share, By Application, 2019 & 2027 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parkinson’s Disease
8.4.1 Overview
8.4.2 Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Schizophrenia
8.5.1 Overview
8.5.2 Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Huntington's Disease
8.6.1 Overview
8.6.2 Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Spinal Muscular Atrophy
8.7.1 Overview
8.7.2 Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Neurological Biomarker Market Analysis– by End User
9.1 Overview
9.2 Neurological Biomarker Market Share, By End User, 2019 & 2027 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Clinical Diagnostics
9.4.1 Overview
9.4.2 Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Organizations
9.5.1 Overview
9.5.2 Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
10. Neurological Biomarker Market Analysis and Forecasts To 2027 – Geographical Analysis
10.1 Middle East and Africa: Neurological Biomarker Market
10.1.1 Overview
10.1.2 Middle East and Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)
10.1.3 Middle East and Africa: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.4 Middle East and Africa: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)
10.1.5 Middle East and Africa: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)
10.1.6 Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
10.1.7 Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Saudi Arabia: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.7.3 Saudi Arabia: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)
10.1.7.4 Saudi Arabia: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)
10.1.8 UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UAE: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.8.3 UAE: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)
10.1.8.4 UAE: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)
10.1.9 South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Africa: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.9.3 South Africa: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)
10.1.9.4 South Africa: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East and Africa Neurological Biomarker Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bio-Rad Laboratories Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 QIAGEN
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Immunarray Pvt. Ltd.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Incorporated
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Perkin Elmer, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 MERCK KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)
Table 3. Middle East and Africa Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 5. Saudi Arabia Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)
Table 6. Saudi Arabia Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 8. UAE Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)
Table 9. UAE Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)
Table 12. South Africa Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Neurological Biomarker Market
LIST OF FIGURES
Figure 1. Neurological Biomarker Market Segmentation
Figure 2. Neurological Biomarker Market – By Country
Figure 3. Middle East and Africa Neurological Biomarker Market Overview
Figure 4. Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market
Figure 5. Middle East and Africa Neurological Biomarker Market- Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 7. Expert Opinion
Figure 8. Neurological Biomarker Market Impact Analysis of Driver and Restraint
Figure 9. Middle East and Africa Neurological Biomarker Market – Revenue Forecast and Analysis – 2019- 2027
Figure 10. Neurological Biomarker Market Share, by Product, 2019 & 2027 (%)
Figure 11. Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Neurological Biomarker Market Share, by Application, 2019 & 2027 (%)
Figure 17. Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Neurological Biomarker Market Share, by End User, 2019 & 2027 (%)
Figure 24. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Middle East and Africa: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. Middle East and Africa Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
Figure 29. Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
Figure 30. Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
Figure 31. UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
Figure 32. South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in Middle East and Africa Countries Market
- Thermo Fisher Scientific Inc.
- Abbott
- Bio-Rad Laboratories Inc.
- QIAGEN
- Immunarray Pvt. Ltd.
- Quest Diagnostics Incorporated
- Perkin Elmer, Inc
- MERCK KGaA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Neurological Biomarker Market
Apr 2021
Type-C Tanks Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Tank Type (Cylindrical, Bi-lobe, and Tri-lobe), Application (Cargo Tanks and Fuel Tanks), End User (LNG, LPG, LH2, and Ethanol), and Geography
Apr 2021
Water Treatment Industry Valves Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Valve Type (Ball Valves, Butterfly Valves, Diaphragm Valves, Safety Valves, Check Valves, Gate Valves, and Others) and Material Type (Steel Alloys, Stainless Steel, Cast Iron, and Others)
Apr 2021
Construction Scaffolding Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Offering [Scaffolding Products (Sale) and Rental Solutions], Type (Frame Scaffolding, Tube and Clamp Scaffolding, Ringlock Scaffolding, Cuplock Scaffolding, and Others), and End User (Residential Building, Commercial Building, Industrial, Oil and Gas Industry, Events, and Others)
Apr 2021
Conventional Lathe Machine Market
Forecast to 2028 - Global Analysis by Spindle Orientation (Horizontal and Vertical), Number of Axis (2 and 3), End-User (Automotive, General Machinery, Aerospace, Electronics, Oil & Gas, Others), and Lathe Type (Universal Lathe and Oil Country Lathe)